| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |